Bone morphogenetic protein-2 (BMP-2)-containing bone grafts are useful regenerative materials for oral and maxillofacial surgery; however, several invitro and invivo studies previously reported cancer progression-related adverse effects caused by BMP-2. This evidence concerns the gene BMP2 and cancer.